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ABSTRACT
Davis, GR, Stephens, JM, and Nelson, AG. Effect of 12
weeks of periodized resistance training upon total plasma
adiponectin concentration in healthy young men. J Strength
Cond Res 29(11): 3097–3104, 2015—The effects of resis-
tance training on adiponectin have thus far yielded equivocal
results. However, the effect of periodized resistance training
on plasma adiponectin in offspring of type 2 diabetic and
nondiabetic (ND) parents (first-degree family history) has
yet to be determined. Untrained healthy young men with
and without a first-degree family history of type 2 diabetes
were assigned to an exercise intervention group (E) or an
active control group (C). The E group performed a 12-
week periodized resistance training program, whereas the
C group did not participate in any structured exercise pro-
gram. Fasting plasma samples were obtained pre- and post-
training. Total plasma adiponectin changed significantly in
the E group (33.7 6 14.7%, p = 0.025) but not in the C
group (10.8 6 19.2%). Offspring of type 2 diabetic parents
subjects had significantly greater improvements in plasma
adiponectin (69.3 6 34.8%) compared with ND subjects
(23.2 6 29.9%, p = 0.046). Regular aerobic exercise was
significantly correlated with average plasma adiponectin (r =
0.32), whereas first-degree family history of type 2 diabetes
(r = 20.58) and decreases in body fat percentage (r =
20.77) were inversely correlated with average plasma adi-
ponectin. Periodized high-intensity resistance training seems
to increase plasma adiponectin, particularly in individuals
with a first-degree family history of type 2 diabetes or those
who experience a significant loss of fat mass. The direct
correlation between regular aerobic exercise and adiponec-
tin further suggests that a combination of aerobic and
resistance training yields greater improvements in plasma
adiponectin compared with resistance training alone.




he offspring of type 2 diabetic (OD) parents are
often referred to as individuals with a first-degree
family history of diabetes. These individuals are at
a greater risk for developing type 2 diabetes com-
pared with the offspring of nondiabetic (ND) parents because
of a greater genetic predisposition to the disease (3). Not only
is it important for OD to identify early signs of insulin resis-
tance to prevent the progression of the disease, but it is also
important for these individuals to find mechanisms to
actively enhance insulin sensitivity. One biomarker that has
been shown to be directly suppressed in OD is the circulat-
ing levels of the adipocyte-derived hormone, adiponectin,
which plays an important role in insulin sensitivity and glu-
cose and lipid metabolism (9,19). In addition to its role in the
regulation of glucose and lipid metabolism, adiponectin has
anti-inflammatory properties (34). Chronic low-grade
inflammation, which is associated with obesity, diabetes,
and cardiovascular disease, is also associated with low levels
of circulating adiponectin, as reviewed by Ouchi and Walsh
(32). Thus, adiponectin has been deemed as an anti-
inflammatory adipokine (34) and has shown to play an
important role in the suppression of inflammation and is
associated with enhanced insulin sensitivity. Adiponectin
levels are generally elevated among healthy lean populations
and suppressed among obese, insulin-resistant, or type 2
diabetic populations (9). Although lifestyle modifications,
specifically exercise intervention studies, have irrefutably
demonstrated numerous benefits in the prevention of type
2 diabetes via enhanced glucose uptake and insulin sensitiv-
ity (6,11,16), plasma adiponectin responses to exercise are
much less clear, particularly in OD populations.
Long-term exercise training has been shown to reduce
inflammation (15), improve insulin sensitivity (29), and
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improve blood lipid (25) and glucose profiles (7). Therefore,
exercise should theoretically be an effective method for
increasing plasma adiponectin levels. Thus far, however,
highly variable responses have been observed in studies
examining exercise-induced changes in plasma adiponectin.
Several studies have demonstrated that plasma adiponectin
tends to increase after chronic high-intensity exercise train-
ing (13,21) or in the presence of weight loss (26,37), whereas
other studies show no change in plasma adiponectin after an
exercise intervention despite enhanced insulin action (17,29).
Up to this point, no studies to our knowledge have examined
responses to a periodized resis-
tance training program.
Periodized resistance training
programs have been shown to





programs. Therefore, it is pos-
sible that periodized resistance
training programs may induce
changes in plasma adiponectin
that have not been observed in
previous studies, which in large
part, have implemented non-
periodized resistance training
programs. Furthermore, several
studies have examined exercise
responses in aging and type 2
diabetic populations (5,27), but few have examined young
nondiabetic individuals. Of those studies, it is unknown
whether the parents of the young healthy subjects had type
2 diabetes. By examining healthy young individuals with and
without type 2 diabetic parents, it may be possible to deter-
mine whether genetic variation affects circulating levels of
adiponectin after an exercise training intervention.
The purpose of the current study was to determine if a 12-
week periodized high-intensity resistance training program
would elicit changes in circulating plasma adiponectin levels in
healthy young men with and without a first-degree family
history of type 2 diabetes. If periodized resistance training is
effective in improving plasma adiponectin levels in the absence
of weight loss, particularly in OD men, practitioners should
consider using this type of training program, even for non-
athlete populations, as opposed to a nonlinear training cycle
for individuals with a first-degree family history of type 2
diabetes. We hypothesized that adiponectin levels would
increase after the exercise intervention and that greater
changes would be observed in the OD compared with the ND.
METHODS
Experimental Approach to the Problem
Currently enrolled students at the university were recruited
to participate in the study and were randomly assigned to
the exercise intervention (E) or active control (C) groups.
The E group participated in a 12-week exercise intervention,
whereas the C group maintained their normal exercise habits
but did not engage in any structured exercise program for
the duration of the study. An additional 1 week of
familiarization and baseline testing was included at the onset
of the study and a 1-week follow-up for retesting was also
included at the conclusion of the study for both groups; thus,
the total duration of the study was 14 weeks. To minimize
subject variability and minimize extraneous variables,
TABLE 1. Comparison of baseline characteristics for the E and C groups.*
Subject characteristics C (n = 12) E (n = 12) p
Age (y) 22.1 6 1.0 20 6 0.3 0.074152
Weight (kg) 85.8 6 1.1 82.5 6 2.8 0.506933
BMI 28.1 6 1.2 25.9 6 1.0 0.178958
Percent body fat 23.8 6 6.0 19.3 6 1.3 0.052728
Family history T2D (%) 16.7 6 11.2 38.5 6 14.0 0.238284
Reg. aerobic ex. (%) 33.3 6 14.2 23.1 6 12.2 0.588996
Reg. resistance ex. (%) 41.7 6 14.9 15.4 6 10.4 0.16309
Reg. caffeine (%) 38. 6 6 8.5 53.8 6 15.4 0.29461
*C = active control group; E = exercise group; BMI = body mass index; Family history T2D
(%) = percentage of participants who reported mother or father with type 2 diabetes; Reg.
aerobic ex. (%) = percentage of participants who reported regular aerobic exercise; Reg.
resistance ex. (%) = percentage of participants who reported regular resistance exercise;
Reg. caffeine (%) = percentage of participants who reported regular caffeine consumption.
Values are presented as mean 6 SD.






2 3 10 60
3 3 6 70
4 6 10 60
5 3 4 80
6 3 8 60
7 4 6 70
8 4 2 85
9 5 5 80
10 3 12 55
11 4 4 85
12 3 6 70
13 5 4 85
14 Repeat baseline
testing
*%1RM = percentage of 1 repetition maximum.
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subjects were asked to abstain from alcohol and caffeine
consumption and strenuous physical activity for 48 hours
before baseline testing. All procedures were repeated after
the conclusion of the exercise intervention to determine
changes in plasma adiponectin and changes in anthropo-
metric measures.
Subjects
Untrained healthy men (n = 24) who were a minimum of 18
years of age, range 18–33 years (average 6 SD) (21.8 6 3.8)
with a body mass index ,30 were recruited to participate in
the study. The E group consisted of 4 OD subjects and 8 ND
subjects. The C group consisted of 2 OD subjects and 10 ND
subjects. All subjects were non-
smokers, were not taking any
medication, and did not partic-
ipate in any structured resis-
tance training exercise
program for the previous 6
months. Baseline subject char-
acteristics were not statistically
different between groups as
shown in Table 1. All subjects
were healthy as indicated by
the Physical Activity Readiness
Questionnaire. Informed consent
was obtained from all subjects
before the onset of the first exer-
cise trial, and the study protocol
was approved by the University’s
Institutional Review Board.
Procedures
After 48 hours of rest period,
subjects arrived at the labora-
tory after an overnight fast. Ten
milliliters of blood were drawn
from the cubital vein via veni-
puncture to determine initial plasma adiponectin values.
Blood was collected into sodium heparin vacutainers (Becton,
Dickinson and Company, Franklin Lakes, NJ, USA); plasma
was then separated and stored at2808 C until further analysis.
Height and weight were measured using a Detecto medical
scale (Cardinal Scale Manufacturing Co., Webb City, MO,
USA), body fat was determined via the 7-site skinfold tech-
nique using Lange skinfold calipers (Beta Technology, Inc.,
Cambridge, MD, USA) and included the chest, triceps, abdo-
men, thigh, suprailiac, subscapular, and midaxillary sites, per
the American College of Sports Medicine (ACSM) guidelines
(1), and the International Physical Activity Questionnaire was
used to determine exercise habits. First-degree family history
of type 2 diabetes was determined by asking each subject if his
mother or father had been diagnosed with type 2 diabetes.
Caffeine consumption was determined by asking each subject
how many cups of coffee, tea, soda, energy drinks, and energy
shots were typically consumed in a week. Regular caffeine
consumption was considered a combination of any of the
following equating to $5 per week: 8 ounce cup of coffee
or tea, 12 ounce caffeinated soda, or 1 energy shots or drinks.
Regular aerobic exercise was considered $150 minutes of
total aerobic exercise per week, as per the ACSM guidelines.
All baseline measurements and testing procedures were
repeated at the conclusion of the exercise intervention after
48 hours of abstinence from alcohol consumption, caffeine
consumption, and strenuous physical activity.
Exercise Protocol
As outlined in Table 2, after a familiarization session, the
initial strength of each subject was determined by 1
Figure 1. Exercise intervention modestly increases circulating levels of total adiponectin. Bar graphs represent
relative optical densities of total adiponectin (ADPN) normalized to the respective pre-exercise control band
intensities derived from the same gel. *p# 0.05 compared with pre-exercise; – = pre-exercise; + = postexercise; n
= 12 per group. Values are presented as mean 6 SD.
Figure 2. Changes in total adiponectin in diabetic offspring (OD) vs.
nondiabetic offspring (ND). Fold change in plasma adiponectin pre- to
postexercise in OD (n = 4) vs. ND (n = 8) in the E group. *p # 0.05
compared with ND. Values are presented as mean 6 SD.
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repetition maximum (1RM) for free-weight squat, free-
weight bench press, and free-weight deadlift. These values
were then used to determine relative exercise intensity for
these individual exercises. All strength measurements were
repeated upon completion of the 12-week exercise interven-
tion during the retesting week. A week-by-week description
for the exercise intervention is described in Table 2. Resis-
tance training was performed 3 times per week for 40–50 mi-
nutes per exercise session, and each session was supervised
by the research personnel. Each exercise session was sepa-
rated by a minimum of 48 hours. Subjects were required to
participate in a minimum of 80% of the exercise sessions to
be included in the analysis.
Total work volume varied from week to week, and each day
consisted of 3–5 exercises depending on the number of sets
and repetitions. Three exercises were used for high-volume
days, whereas 4 or 5 exercises were used for low-volume days.
For example, Monday of week 2 consisted of 3 sets of 10
repetitions for back squats, Romanian deadlifts, and good
mornings at a lower intensity (3 exercises total), whereas
Wednesday of week 5 consisted of 3 sets of 4 repetitions for
flat bench press, incline bench press, push press, pull-ups, and
bent-over rows at a higher intensity (5 exercises total). Specific
exercises varied from week to week and included back squats,
front squats, flat bench press, incline bench press, conventional
deadlifts, Romanian deadlifts, sumo deadlifts, bent-over rows,
upright rows, good mornings, glut ham raises, pull-ups, lat
pull-downs, and push press. All
exercises were completed with
barbell free weights with the
exception of glut ham raises,
which were done with weight
plates, pull-ups, which were
done with body weight, and lat
pull-downs, which were done
on weight-stacked machine.
To minimize the risk of over-
training and injury, no single
muscle group was targeted on
consecutive exercise sessions.
Plasma Analysis
All plasma samples were analyzed to determine the level of
total plasma adiponectin via Western blot. Protein was
quantified for each sample as determined by bicinchoninic
acid assay (Sigma-Aldrich, St. Louis, MO, USA), and equal
amounts of protein from each sample were subjected to
electrophoresis. Samples were separated in 7.5% polyacryl-
amide (acrylamide from National Diagnostics) gels contain-
ing sodium dodecyl sulfate and transferred to a nitrocellulose
membrane in 25 mM Tris, 192 mM glycine, and 20%
methanol. After the transfer, the nitrocellulose membrane
was blocked overnight in 4% milk at 48 C and then probed
with human-anti-adiponectin (Thermo Scientific MA1-054)
using a 1:1000 dilution in 1% bovine serum albumin in 13
Tris-buffered saline tween. Results were visualized with
horseradish peroxidase–conjugated mouse-antihuman sec-
ondary antibody (1:1000 in 1% nonfat milk in 13 Tris-
buffered saline tween) and enhanced chemiluminescence.
Densitometric analysis of blots was performed using ImageJ
software, and figures were produced using Prism 6 Graph-
pad software (Graphpad Software, Inc., La Jolla, CA, USA).
Statistical Analyses
Baseline subject characteristics between E and C groups
were analyzed using an unpaired t-test. Paired t-tests were
used to determine changes in strength and plasma adiponec-
tin pre- to postintervention within groups. A 2-way analysis
of variance was used to compare fold changes in adiponectin
in the C and E groups and OD
and ND. Associations between
variables were investigated
using Pearson’s correlation
analyses, and significant differ-
ences were identified using Tu-
key post hoc tests. Multiple
linear regression analysis was
used to determine the degree
of contribution of first-degree
family history, changes in body
weight, and changes in body
fat percentage to explain
plasma adiponectin levels. An
TABLE 3. Comparison of fold change in plasma adiponectin pre- to
postintervention.*
Group NDC NDE ODC ODE
Average fold change 0.35 6 0.57 0.03 6 0.3 20.47 6 0.07 0.69 6 0.35†
*NDC = nondiabetic control group (n = 10); NDE = nondiabetic exercise group (n = 9);
ODC = diabetic offspring control group (n = 2); ODE = diabetic offspring exercise group (n =
3). Values are presented as mean 6 SD.
†p # 0.05 compared with NDE.
TABLE 4. Comparison of change in body fat percentage between groups pre- to
postintervention.*
Group NDC NDE ODC ODE
Change 20.36 6 0.71 20.20 6 2.10 1.14 6 0.41 22.20 6 0.40†
*NDC = nondiabetic control group (n = 10); NDE = nondiabetic exercise group (n = 9);
ODC = diabetic offspring control group (n = 2); ODE = diabetic offspring exercise group (n =
3). Values are presented as mean 6 SD.
†p # 0.05 compared with NDE.
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alpha level of 0.05 was used to determine statistical signifi-
cance. Power or effect size was determined for statistically
significant results. All values are presented as mean6 SD. All
statistical analyses were completed using SAS version 9.2
(SAS Institute, Inc., Cary, NC, USA).
RESULTS
The exercise intervention had minor, but significant, effects
on plasma adiponectin concentration (p = 0.025, h2 = 0.03).
The average fold change in plasma adiponectin expression in
E group was 0.34 6 0.15 compared with baseline values,
whereas the average fold change in plasma adiponectin
expression in C group was 0.19 6 0.19 (Figure 1). When
the E group was separated into OD and ND subjects,
changes in adiponectin were significantly different between
the 2 populations (p = 0.046, h2 = 0.034). The average fold
change in plasma adiponectin expression in the OD subjects
was 0.69 6 0.35, whereas ND subjects exhibited almost no
change in adiponectin (20.03 6 0.30, Figure 2). Thus, the
differences in fold changes in plasma adiponectin found in
the E group pre- to postexercise were primarily because of
changes found in the OD subjects. The average fold change
in plasma adiponectin expression in the OD subjects of the
control group (ODC) was 20.47 6 0.07, whereas the aver-
age fold change in plasma adiponectin expression in the ND
subjects of the control group (NDC) was 0.35 6 0.57,
although differences were not significant. Similarly, fold
changes in plasma adiponectin were not significantly differ-
ent between OD subjects in the exercise group (ODE) vs.
ODC because of the small number of OD subjects in each
group, and no statistical differences were found between ND
subjects in the exercise group (NDE) vs. NDC. Differences
in fold changes between groups are summarized in Table 3.
Although not statistically significant, body fat percentage
decreased from 19.3 6 1.3% pretraining to 17.5 6 1.1% post-
training in the E group, whereas no change occurred in the C
group (23.8 6 6.0% pretraining to 23.1 6 4.4% posttraining).
Offspring of type 2 diabetic subjects in the control group had
an initial body fat percentage of 22.2 6 6.25%, whereas the
NDC had an initial body fat percentage of 22.1 6 4.33%.
Similarly, ODE had an initial body fat percentage of 15.0 6
1.8%, whereas the NDE had an initial body fat percentage of
19.4 6 4.9%. The differences between OD and ND subjects
were not significant for the E or C group at baseline. Changes
in body composition for the NDC, ODC, ODE, and NDE are
reported in Table 4. Differences
between ODE and NDE
groups were significant (p ,
0.01, h2 = 0.03). Neither differ-
ences between ODE and ODC
groups were significant nor
were any other between-group
differences found for body fat
percentage.
Body weight did not
change significantly in either
group or between OD and
ND subjects. Calculated fat-
free body mass (obtained by
subtracting adipose tissue
mass from body weight)
increased in the E group from
64.8 6 6.1 kg before training
to 67.8 6 7.0 kg after training
but was not statistically
significant.




Change in body weight 20.75 ,0.01
Change in BMI 20.35 0.07
Change in body fat (%) 20.77 ,0.01
Family history T2D (%) 20.58 ,0.01
Reg. aerobic ex. (%) 0.32 0.02
Reg. resistance ex. (%) 0.21 0.19
Reg. caffeine (%) 0.25 0.11
*BMI = body mass index; Family history T2D (%) =
percentage of participants who reported mother or father
with type 2 diabetes; Reg. aerobic ex. (%) = percentage
of participants who reported regular aerobic exercise;
Reg. resistance ex. (%) = percentage of participants
who reported regular resistance exercise; Reg. caffeine
(%) = percentage of participants who reported regular
caffeine consumption. Bold indicates statistically signifi-
cant correlations.
Figure 3. Increases in strength for the exercise intervention group. For the E group, 1RM increased from pre- to
postexercise for bench press, squat, and deadlift. 1RM = 1 repetition maximum; E = exercise. *p # 0.05. Values
are presented as mean 6 SD.
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Regular aerobic exercise, changes in body fat percentage,
and changes in body weight significantly correlated with
changes in plasma adiponectin as shown in Table 5. Similarly,
first-degree family history of type 2 diabetes significantly cor-
related with the fold change in adiponectin pre- to postinter-
vention. Changes in plasma adiponectin concentration pre- to
postintervention in the E group were no longer significant
compared with the C group when adjusted for change in
body weight, change in body fat percentage, or first-degree
family history of type 2 diabetes.
As expected, strength, as measured by 1RM, increased
significantly in the E group after training as indicated in
Figure 3. Bench press increased from 97.7 6 18.2 to 101.8 6
16.4 kg, an 8.2% increase, power = 0.80. Squats increased
from 129.5 6 30.5 to 143.2 6 28.2 kg, a 13.4% increase,
power = 0.97. Deadlifts increased from 126.4 6 35.5 to
137.3 6 33.2 kg, a 12.2% increase, power = 0.81.
There were no significant changes in strength in the C
group from pre- to postexercise intervention. Bench press
decreased from 105.8 6 18.6 to 104.9 6 21.4 kg, squats
decreased from 131.56 27.1 to 126.96 29.1 kg, and deadlifts
increased from 131.8 6 27.0 to 132.8 6 28.4 kg.
DISCUSSION
The present study suggests that a 12-week periodized high-
intensity resistance training program elicits minor improve-
ments in circulating adiponectin levels, particularly among
type 2 diabetic offspring. Furthermore, regular aerobic
exercise and decreases in body weight or body fat percent-
age are associated with greater increases in plasma adipo-
nectin. These findings are in agreement with previous studies
that have shown increases in adiponectin after weight loss
(37) or exercise in conjunction with weight loss (26). How-
ever, the present study did not demonstrate significant
changes in body weight or body fat percentage for the exer-
cise intervention group as a whole despite the significant
increase in plasma adiponectin. Some studies have observed
increases in adiponectin in the absence of weight loss among
overweight or obese older populations (22,31), but this is the
first to identify changes among healthy populations. Previous
long-term exercise training studies in healthy populations
have, in large part, found no change (17,29) and in some
cases a decrease (18) in plasma adiponectin after training.
With the exception of the OD subjects in the exercise
intervention group, the findings of the current study further
support the notion that exercise interventions, in the absence
of weight loss, are ineffective in affecting plasma adiponectin
levels in healthy populations. There are several potential
explanations as to why plasma adiponectin significantly
increased among OD subjects in the exercise intervention
group of the current study. One reason may be partially
because of the high-intensity periodized resistance training
protocol used. Fatouros et al. (13) determined that changes
in adiponectin after resistance training are directly related to
exercise intensity. Although exercise intensity varied from
week to week in the current study, the overall program
was considered “high intensity” for untrained individuals
given that it elicited significant gains in strength as demon-
strated by increases in 1RM for bench press, squats, and
deadlifts. The majority of previous resistance training studies
investigating adiponectin involved nonperiodized programs
(13,18,31). This type of program is less effective than perio-
dized training programs for increasing strength (24), and
therefore, metabolic, inflammatory, and endocrine adapta-
tions are likely to be blunted as well. Given the enhanced
gains in strength after a periodized training program com-
pared with a nonperiodized training program, the current
study suggests that adiponectin responses may also be
enhanced. A recent study examining changes in plasma adi-
ponectin and plasma leptin after 8 weeks of undulating peri-
odization compared with nonperiodized or a linear
periodization program noted a trend for greater strength
gains, increases in adiponectin, and decreases in leptin (2).
Though differences between exercise groups were not sig-
nificant, the authors suggested that longer duration
population-specific studies may reveal significant differences,
as found in the current study. This further reinforces the
notion that undulating periodization programs may enhance
metabolic parameters more effectively than nonperiodized
programs and therefore elicit superior health benefits in at-
risk populations.
Although the type of training may have had a large effect on
plasma adiponectin in the E group as a whole, a large degree
of variation was found for individual responses to the exercise
training. Some of this variation is likely because of genetic
predisposition as seen in OD vs. ND subjects. As demonstrated
in the current study and in previous studies, plasma adipo-
nectin levels are highly variable among healthy (14,17) and
overweight, diabetic, or insulin-resistant populations (34,35).
Thus, changes in plasma adiponectin concentration pre- to
postexercise intervention in OD and ND had considerable
variation. Although most subjects in the E group increased
circulating adiponectin pre- to postexercise, some actually
decreased adiponectin pre- to postexercise. Some studies have
shown decreases in adiponectin after exercise (18,20), and it
has been suggested that very high adiponectin levels are asso-
ciated with all-cause mortality (8). Therefore, although abso-
lute adiponectin concentration was not measured in the
current study, it is possible that ND had higher initial adipo-
nectin values at the onset of the study compared with OD, and
as a result, decreases or no changes were observed in this
population. This could be a protective effect to prevent too
high of a concentration of this hormone. However, additional
research is needed to investigate this issue in detail.
Data from the current study also demonstrated a greater
decrease in body fat percentage in OD subjects compared
with ND subjects in the E group. Although group differences
were statistically significant, the number of ODE was only 3,
making the effect size relatively small. Furthermore, there is an
estimated 3.5% degree of error in a repeated 7-site skinfold
Periodized Resistance Training and Adiponectin
3102 Journal of Strength and Conditioning Research
the TM
Copyright © National Strength and Conditioning Association Unauthorized reproduction of this article is prohibited.
measurement (12). Although the same technician performed
all skinfold measurements for all subjects pre- and postinter-
vention, with such a limited sample size, it is difficult to attri-
bute changes in body fat, which has a large degree of
variability, directly to changes in adiponectin in the current
study. Table 5 indicates that changes in body fat percentage
had an inverse correlation with fold changes in adiponectin. A
relationship between these 2 variables clearly exists and may
have contributed to differences between groups, but no defin-
itive statement can be made based on the data available in the
current study. Thus, although weight loss and decreases in
body fat percentage are linked with increased levels of adipo-
nectin, other factors, such as overall inflammatory state (34)
and reaching “optimal” levels of circulating adiponectin (8),
may be more directly involved in the regulation of plasma
adiponectin levels after long-term exercise training.
Given that weight loss is associated with elevated levels of
adiponectin and decreased inflammatory markers (26), it is
possible that the overall inflammatory state and potentially
specific inflammatory signaling molecules account for some
of the variations in plasma adiponectin expression in the
current study and in previous studies. Even in the absence
of weight loss, exercise has been shown to reduce inflamma-
tion in some cases (4), but not others (29,30). The differences
in these findings seem to be related to exercise intensity.
Long-term high-intensity exercise yields a reduction in
inflammation (3), whereas lower intensity exercise does
not change inflammatory markers, including adiponectin
(26). Therefore, although inflammatory markers were not
measured in the current study, it is possible that the high-
intensity periodized resistance training program used in the
current study induced changes in plasma adiponectin via
a decrease in the overall inflammatory state of the individual.
Although it would have been ideal to have a greater number
of OD subjects in both groups, we were limited in our
population availability. Since our subject population average
age was approximately 22 years, finding participants with type
2 diabetic parents proved to be a difficult undertaking. The
incidence of type 2 diabetes is more prevalent in older
individuals (36), and in large part, the average age of the par-
ticipants’ parents for the current study was less than 50 years,
thereby limiting the OD population as a whole. Because of
time constraints, we could not extend the study for an addi-
tional year to recruit additional participants, and thus, the OD
vs. ND population was unbalanced. Furthermore, we recog-
nize that the small number of OD participants is a limitation of
current study, and further investigation is clearly warranted to
more definitely establish differences in changes in plasma adi-
ponectin expression after long-term exercise.
It is also worth noting that the relative level of plasma
adiponectin for the current study was measured using
a Western blot technique, as opposed to the measurement
of absolute concentration of adiponectin via enzyme-linked
immunosorbent assay or radioimmunoassay. Although spe-
cific concentration of adiponectin could not be determined
pre- and postexercise using a Western blot technique, it did
eliminate issues associated with plasma volume shifts (10).
Also, plasma adiponectin concentration in humans varies
considerably in healthy populations. Some studies report
concentrations as low as 6 mg/ml (17), whereas other studies
report concentrations as high as 20 mg/ml (14). Thus, the
current study eliminated the issue of potentially skewed data
by determining relative change rather than absolute values.
PRACTICAL APPLICATIONS
In addition to the well-established neuromuscular and
metabolic adaptations of periodized strength and condition-
ing programs, these programs may offer protective benefits
in the prevention of type 2 diabetes via increased circulating
adiponectin, particularly among OD who are at a greater
disposition for developing the disease. Even among ND,
periodized resistance training programs may help keep
adiponectin levels in an optimal range that is associated
with insulin sensitivity without reaching excessive levels that
can be associated with detrimental health effects. The
current data suggest that periodized resistance training is
beneficial not only to athletes from a performance perspec-
tive but also to the general population from a health
perspective. Furthermore, the current study and the study
by Ahmadizad et al. (2) suggest that undulating periodiza-
tion resistance training programs may offer superior meta-
bolic benefits compared with linear or nonperiodized
resistance training programs. Finally, the addition of regular
aerobic exercise and weight loss can enhance the levels cir-
culating adiponectin and further improve metabolic health in
both ND and OD populations. Incorporating aerobic exer-
cise into a periodized resistance training program, therefore,
is likely to provide additional benefits. Further improvements
may be seen in the case of weight loss or body fat loss.
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